Sep 17 2019
1:30 PM - 3:00 PM

If you find the FDA's regulatory framework regarding regenerative medicine and stem cell therapies confusing, you're not alone. During this webinar, "Regenerative Medicine and Stem Cell Regulation," Buchanan's Barbara Binzak Blumenfeld, Ph.D. will explain the current regulatory framework and FDA's interpretation, enforcement actions not only from FDA, but FTC and the states, and opportunities for the legal development and use of stem cells.  

Attendees will gain an understanding of the FDA's regulations and enforcement, and how stem cell stakeholders (pharma/biotech companies, healthcare providers) can best comply.

Additional information and registration available here.